Literature DB >> 10616748

International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Standardization Project for the Measurement of Lipoprotein(a). Phase 2: selection and properties of a proposed secondary reference material for lipoprotein(a).

J R Tate1, K Berg, R Couderc, F Dati, G M Kostner, S M Marcovina, N Rifai, I Sakurabayashi, A Steinmetz.   

Abstract

The International Federation of Clinical Chemistry and Laboratory Medicine Working Group for the Standardization of Lipoprotein(a) Assays has initiated a project to select a secondary reference material for lipoprotein(a) that can standardize the measurement of this lipoprotein. Most of the analytical problems with lipoprotein(a) assays are due to apolipoprotein(a) kringle 4 type 2 reactive antibodies and values being expressed in mg/l mass units rather than as nmol/l of apolipoprotein(a) particles. In Phase 2, four manufactured materials were compared for analytical performance, commutability properties and method harmonization in 27 lipoprotein(a) test systems. Results of precision and linearity testing were comparable for all materials whereas testing for the harmonization effect resulted in an among-assay coefficient of variation for corrected lipoprotein(a) values of between 11% and 22%. The material that gave maximum harmonization achieved a variation of < 8% for 18 immunonephelometric and immunoturbidimetric assay systems. It can be hypothesized that this residual variation in part takes into account the inaccuracy of lipoprotein(a) measurement due to apolipoprotein(a) size polymorphism. On the basis of acceptable analytical performance, maximal harmonization effect and documented stability, a lyophilized material has been selected as the common calibrator for lipoprotein(a) to be used in a value transfer procedure by diagnostic companies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10616748     DOI: 10.1515/CCLM.1999.140

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  16 in total

Review 1.  Lipoprotein (a) measurements for clinical application.

Authors:  Santica M Marcovina; John J Albers
Journal:  J Lipid Res       Date:  2015-12-04       Impact factor: 5.922

2.  Mealtime habits and risk of developing the metabolic syndrome or insulin resistance among Mexican adults.

Authors:  Pablo Méndez-Hernández; Libia Darina Dosamantes-Carrasco; Carole Siani; Romain Pierlot; Margarita Martínez-Gómez; Berenice Rivera-Paredez; Laura Cervantes-Popoca; Elodia Rojas-Lima; Eduardo Salazar-Martínez; Yvonne N Flores; Jorge Salmerón
Journal:  Br J Nutr       Date:  2016-11-15       Impact factor: 3.718

3.  Association between different growth curve definitions of overweight and obesity and cardiometabolic risk in children.

Authors:  Lisa Kakinami; Mélanie Henderson; Edgard E Delvin; Emile Levy; Jennifer O'Loughlin; Marie Lambert; Gilles Paradis
Journal:  CMAJ       Date:  2012-04-30       Impact factor: 8.262

Review 4.  The role of lipoprotein[a] in atherosclerosis.

Authors:  J D Morrisett
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

5.  Comparison of different severe obesity definitions in predicting future cardiometabolic risk in a longitudinal cohort of children.

Authors:  Lisa Kakinami; Anna Smyrnova; Gilles Paradis; Angelo Tremblay; Melanie Henderson
Journal:  BMJ Open       Date:  2022-06-15       Impact factor: 3.006

6.  Dietary glycemic index, dietary glycemic load, blood lipids, and coronary heart disease.

Authors:  Edgar Denova-Gutiérrez; Gerardo Huitrón-Bravo; Juan O Talavera; Susana Castañón; Katia Gallegos-Carrillo; Yvonne Flores; Jorge Salmerón
Journal:  J Nutr Metab       Date:  2010-02-28

Review 7.  Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases.

Authors:  Florian Kronenberg
Journal:  Cardiovasc Drugs Ther       Date:  2016-02       Impact factor: 3.727

8.  Association between Vitamin D Deficiency and Single Nucleotide Polymorphisms in the Vitamin D Receptor and GC Genes and Analysis of Their Distribution in Mexican Postmenopausal Women.

Authors:  Berenice Rivera-Paredez; Nayeli Macías; Mayeli M Martínez-Aguilar; Alberto Hidalgo-Bravo; Mario Flores; Amado D Quezada-Sánchez; Edgar Denova-Gutiérrez; Miguel Cid; Angelica Martínez-Hernández; Lorena Orozco; Manuel Quiterio; Yvonne N Flores; Jorge Salmerón; Rafael Velázquez-Cruz
Journal:  Nutrients       Date:  2018-08-27       Impact factor: 5.717

9.  Physical activity and risk of metabolic syndrome in an urban Mexican cohort.

Authors:  Pablo Méndez-Hernández; Yvonne Flores; Carole Siani; Michel Lamure; L Darina Dosamantes-Carrasco; Elizabeth Halley-Castillo; Gerardo Huitrón; Juan O Talavera; Katia Gallegos-Carrillo; Jorge Salmerón
Journal:  BMC Public Health       Date:  2009-07-31       Impact factor: 3.295

10.  Accuracy of body fat percent and adiposity indicators cut off values to detect metabolic risk factors in a sample of Mexican adults.

Authors:  Nayeli Macias; Amado D Quezada; Mario Flores; Mauro E Valencia; Edgar Denova-Gutiérrez; Manuel Quiterio-Trenado; Katia Gallegos-Carrillo; Simon Barquera; Jorge Salmerón
Journal:  BMC Public Health       Date:  2014-04-10       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.